CD44 -- A New Prognostic Marker for Neuroblastoma
Authors:
- M.C. FavrotMFM.C. Favrot
- V. CombaretVCV. Combaret
- C. LassetCLC. Lasset
- 23 December 1993
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 329 (26) , 1965
Abstract
CD44 is a cell-surface glycoprotein involved in cell-cell and cell-matrix interactions1. CD44 isoforms are expressed during progression and metastasis in colon and breast cancer and in non-Hodgkin's lymphoma2-4. We investigated the prognostic importance of the expression of CD44 in neuroblastoma, one of the most common cancers in children.Keywords
This publication has 5 references indexed in Scilit:
- Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.Journal of Experimental Medicine, 1993
- Expression of CD44R1 adhesion molecule in colon carcinomas and metastasesThe Lancet, 1993
- Significance of CD44 gene products for cancer diagnosis and disease evaluationThe Lancet, 1992
- A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein familyCell, 1989
- International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.Journal of Clinical Oncology, 1988